Company news
Bluenergies Ltd. news in 2014
Bluenergies Ltd.'s news releases, calls and decks from 2014, newest first.
BELLUS Health announces sale of ABCP Notes and settlement of credit facilities
November 26, 2014
Bellus Health Reports Results for Third Quarter Ended September 30, 2014
November 5, 2014
BELLUS Health Reports Results for Second Quarter Ended June 30, 2014
August 13, 2014
Auven Therapeutics and BELLUS Health announce completion of enrollment in the Phase III Confirmatory Study of KIACTA(TM) for the treatment of AA amyloidosis
May 27, 2014
BELLUS Health reports results for first quarter ended March 31, 2014, and provides update on rare disease pipeline
May 7, 2014
Auven Therapeutics and BELLUS Health Announce Engagement of Financial Advisor to Explore Sale of KIACTA(TM), an Experimental Drug in Phase III Development for the Treatment Of AA Amyloidosis
May 7, 2014
Auven Therapeutics and BELLUS Health Announce Licence Agreement with Mount Sinai for KIACTA(TM) in Sarcoidosis
May 2, 2014
BELLUS Health reports results for year ended December 31, 2013
February 26, 2014
BELLUS Health provides update on KIACTA(TM) Phase III orphan drug study
January 9, 2014